Supplementary Table 1- Variables distribution in patients with MIS, TM and in the total group and their frequencies by country.

Distribution of patients according to their respective countries can be found in Supplementary Table 1. To ensure robustness and generalizability of our findings in the context of rare melanomas, this data was subjected to clustering. This approach allows for the examination and applicability of our results across different countries